Fractyl Health, Inc. Common Stock
Veridion Score
Composite trend over time
Why is GUTS moving today?
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for GUTS.
GUTS insider activity
Fractyl Health, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for GUTS.
GUTS contract awards, year to date.
Public federal awards linked to this ticker.
GUTS lobbying filings, year to date.
Registered lobbying filings matched to Fractyl Health, Inc. Common Stock.